The Indiana Financing Authority is the biggest entry on 2025's largest negotiated calendar with $1.5 billion of Indiana ...

In a remarkable display of market performance, Nutex Health Inc. (NUTX) stock has reached a 52-week high, touching an impressive price level of $182.81. With a market capitalization of nearly $966 ...

Waldencast Acquisition Corp. (WALD) stock has touched a 52-week low, trading at $2.01, as the company faces a challenging market environment. According to InvestingPro analysis, the company maintains ...

eBay Inc (NASDAQ:EBAY). shares soared to a 52-week high, reaching a price level of $71.92, as the online marketplace continues to capitalize on the sustained momentum in e-commerce. The company's ...

Universal Insurance Holdings Inc (NYSE: UVE) stock soared to a 52-week high, reaching a price level of $26.53, with a P/E ratio of 11.2 and an attractive dividend yield of 2.91%.The company has ...

Things look to shift a bit by the end of the week, but this zonal flow should keep conditions quiet for at least the next few days. Happy Monday! Have a great day and a better week.

HONG KONG, May 19 (Reuters) - Talking points from the week in Asian football: Sharjah FC from the United Arab Emirates defeated Lion City Sailors 2-1 at the Singaporean side's Bishan Stadium on ...

And last week, flanked by rabbis and other Jewish leaders ... an state assemblyman and former councilman from Brooklyn who represents a large Orthodox population, took offense at Mr. Mamdani ...

Sigma Lithium Co. (NASDAQ:SGML – Get Free Report)’s share price reached a new 52-week low on Friday . The stock traded as low as $6.57 and last traded at $6.72, with a volume of 308555 shares ...

The fund just hit a 52-week high and is up 18.44% from its 52-week low price of $32.76/share. But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term ...

Novo has plunged over 55% since its 52-week high. Charter Communications surged following news of a planned merger with its cable rival, Cox Communications. The deal would create the nation’s ...

UroGen Pharma shares fell to a 52-week low after a Food and Drug Administration document indicated disagreements with the company about certain aspects of studies of bladder cancer drug UGN-102.